SEEGENE, INC.

096530 KRX Pharmaceuticals Pharmaceuticals
KOSDAQ
₩31,550.00
+0.16%
Delayed · cached 15 min

Fair value analysis

096530
SEEGENE, INC.
PharmaceuticalsPharmaceuticals
₩31,550.00
Close used for this calculation
₩32,687.09Fair value
Financial DNA Score
Profitability · Returns · Balance Sheet · Efficiency · Growth
58/100
Profitability21/25
Returns1/25
Balance Sheet23/25
Efficiency13/25
Growth19/25
Good
Quality radar
58Prof.21/25Ret.1/25Eff.13/25B.Sht23/25Growth19/25

Consensus fair value

₩32,687.09
Near FV
▲ +3.6% against the close used
Model range ₩10,479.90 – ₩69,851.70
The lowest and highest of the models that produced a value. This is the spread of the methods, not a price target.

Price target range & 52-week position

Bear₩10,479.90Fair value₩32,687.09Bull₩69,851.70
FairClose
52-week traded range
52W low ₩25,150.0052W high ₩35,650.00

The 52-week range is measured from the stored price history, not estimated.

Valuation summary

Trading close to the consensus fair value

SEEGENE, INC. closed at ₩31,550.00, 3.5% below the consensus fair value of ₩32,687.09 drawn from 10 valuation models.

Financial DNA score 58/100 — Good. P/E of 30.1x against the 20x sector multiple the P/E model uses.

Quantitative summary only — not investment advice.

All valuation models

DCF Valuation
₩48,028.36
+52.2%
Σ[CF×(1+g)^n/(1.10)^n] + TV/(1.10)^10
g=9%, r=10%, tg=3%, n=10yr
Graham Number
₩22,796.23
-27.7%
√(22.5 × EPS × BVPS)
EPS=1046.84, BVPS=22062.94 · outside Graham range (P/E 30.1, P/B 1.4) — asset-light, treat as a rough floor
Graham Formula
₩67,695.65
+114.6%
EPS × (8.5 + 2g) × 4.4 ÷ FD_Rate
g=20%, FD=3.3%
P/E Fair Value
₩20,936.80
-33.6%
EPS × 20x (sector P/E)
EPS=1046.84, Sector P/E=20x
Peter Lynch (PEG)
₩25,186.97
-20.2%
EPS × Growth% (PEG = 1 is fair)
EPS=1046.84, g=24.1%
EV/EBITDA
₩12,677.05
-59.8%
(EBITDA × 18x − Net Debt) ÷ Shares
EBITDA=34.55B
Dividend Discount (DDM)
₩69,851.70
+121.4%
D1 ÷ (r − g) where D1 = D0×(1+g)
D0=1293.55, r=10%, g=8%
Book Value (P/B)
₩10,479.90
-66.8%
BVPS × (ROE−g)÷(r−g) [Justified P/B — RIM-based]
BVPS=22062.94, ROE=4.8%, g=6%, r=10%
Reverse DCF
₩31,550.00
+0.0%
Solve for g: Price = Σ[EPS×(1+g)^n/(1.10)^n] + TV
Implied: 12.7% | Historical: 24.1%
Margin of Safety
₩29,898.19
-5.2%
Avg(DCF, Graham, P/E) × 75% (25% safety buffer)
Avg fair value=39864.26, MoS=25%

Computed on September 12, 2026 from the most recent annual report on file and that day's closing price. Where a company has seen its earnings move sharply since its last annual report, this figure will lag the market.

Educational data only. Not a recommendation to buy, sell or hold any security.

Educational data only. Not a recommendation to buy, sell or hold any security.